Market Focus

Canada Employment Preview: Employment Expected to Rise 20,000 in September

Canada Employment Preview: Employment Expected to Rise 20,000 in September

October 11, 2017 at 12:35 am 0 comments

Employment is expected to rise 20,000 in September after the 22,200 gain in August. Action Economics said it expects annual average weekly earnings growth to expand at a 1.8% year-on-year pace in September, matching the pace in August but up from the 1.3% growth rates in May, June and July. While that would again be above the multi-year low 0.7%Read More

Coeur Mining Reports Improved Q3 Silver Equivalent Production But Lowers 2017 Guidance

Coeur Mining Reports Improved Q3 Silver Equivalent Production But Lowers 2017 Guidance

October 11, 2017 at 12:34 am 0 comments

Coeur Mining (CDE) reported late Thursday that Q3 production was 9.5 million silver equivalent ounces, comprised of 4.0 million silver ounces and 93,293 gold ounces. Q3 silver equivalent production increased 7% quarter-over-quarter and 10% year-over-year. The quarterly increase in silver equivalent production was driven by a 13% increase in gold production while higher year-over-year silver equivalent production was due toRead More

Royal Gold Fiscal Q1 Gold Equivalent Ounces Slips Sequentially

Royal Gold Fiscal Q1 Gold Equivalent Ounces Slips Sequentially

October 11, 2017 at 12:33 am 0 comments

Royal Gold (RGLD) said late Thursday that its wholly owned subsidiary, RGLD Gold AG, sold about 61,000 gold equivalent ounces in the fiscal Q1 of 2018, down from 62,000 ounces sold in the prior quarter. The Q1 figures include roughly 48,000 gold ounces, 537,000 silver ounces and 1,170 tonnes of copper. The average realized gold, silver, and copper prices perRead More

Acorda Therapeutics Receives Refusal to File Letter from FDA for Inbrija New Drug Application

Acorda Therapeutics Receives Refusal to File Letter from FDA for Inbrija New Drug Application

August 30, 2017 at 5:37 pm 0 comments

Acorda Therapeutics (ACOR) that it received a refusal to file (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for Inbrija. Inbrija is an investigational treatment for patients with Parkinson’s disease taking a carbidopa/levodopa regimen. Tne FDA determined that the NDA, submitted in June, was not sufficiently complete to permit a substantive review.Read More

Dollar Tree Reports Higher Than Projected Fiscal Q2 Results

Dollar Tree Reports Higher Than Projected Fiscal Q2 Results

August 24, 2017 at 2:56 pm 0 comments

Dollar Tree jumped in premarket trading on Thursday after the operator of discount variety stores reported higher-than-expected profit and sales for its fiscal Q2 and boosted its FY17 outlook. Shares gained as much as 8.8%. EPS increased 36.1% to $0.98 in the period ended July 29. That beat the $0.87 average estimate of analysts surveyed by Capital IQ. Fiscal Q2Read More

AstraZeneca Collaborates With Ethris

AstraZeneca Collaborates With Ethris

August 21, 2017 at 4:01 pm 0 comments

AstraZeneca and its biologics research and development arm MedImmune have entered into a five-year strategic research collaboration with Ethris, a German developer of mRNA-based drugs with a focus on pulmonary disease. The collaboration will target the development of RNA therapies for respiratory diseases using Ethris’ proprietary SNIM RNA technology, Ethris said in a statement. Under the agreement, AstraZeneca will payRead More

Ares Management Makes Investment in DuPage Medical Group

Ares Management Makes Investment in DuPage Medical Group

August 16, 2017 at 2:27 pm 0 comments

Physician Group DuPage Medical Group said Wednesday it has entered a strategic partnership under which funds managed by the private equity group of Ares Management LP (ARES) have invested $1.45 billion. DuPage said the investment by Ares will enable continued support for growth initiatives across the entire organization, including the company’s practice management company, DMG Practice Management Solutions, and DuPageRead More